bm 13505 has been researched along with Necrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lefer, AM; Ma, XL; Viehman, GE | 1 |
| Bhat, AM; Lefer, AM; Osborne, JA; Sacks, H | 1 |
2 other study(ies) available for bm 13505 and Necrosis
| Article | Year |
|---|---|
Daltroban, a thromboxane receptor antagonist, protects the myocardium against reperfusion injury following myocardial ischemia without protecting the coronary endothelium.
Topics: Animals; Cats; Coronary Vessels; Endothelium, Vascular; Male; Myocardial Reperfusion Injury; Myocardium; Necrosis; Peroxidase; Phenylacetates; Sulfonamides; Thromboxanes; Vasoconstriction | 1990 |
Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.
Topics: Acute Disease; Animals; Blood Pressure; Cats; Coronary Disease; Creatine Kinase; Electrocardiography; Heart Rate; Male; Myocardial Reperfusion Injury; Myocardium; Necrosis; Phenylacetates; Sulfonamides; Thromboxanes | 1989 |